A study on the use of Systemic Steroids and its combination with Remdesivir in Hospitalized COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/02/040400
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals 18 or older with confirmed COVID-19 disease
Patients on Systemic corticosteroids and its combination with Remdesivir
Exclusion Criteria
Patients tranferred to another facility without completion of treatment
Patients over 90 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to clinical improvement, In-hospital mortality, Time to death, Progression to mechanical VentilationTimepoint: February 2022 July 2022
- Secondary Outcome Measures
Name Time Method Change in Inflammatory Markers level , Adverse eventsTimepoint: February 2022 ,July 2022